According to Thomas Kaye RPh, MBA with of , the frequency of prescribing and reimbursement claims for compounded drugs has been increasing for many plans in recent years—he cautions that incidents associated with the use of such unapproved products “add to overall patient cost, as well as morbidity and mortality.'' [45]
quoted from here
quoted from here
No comments:
Post a Comment